Effects of Dapagliflozin on Progression of Alport Syndrome
NCT06226896
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
222
Enrollment
OTHER
Sponsor class
Conditions
Alport Syndrome
Interventions
DRUG:
Dapagliflozin 10mg Tab
Sponsor
Nanjing University School of Medicine